Skip to main content
. 2022 Dec 8;13:1043366. doi: 10.3389/fendo.2022.1043366

Table 4.

The nocturnal 6-Sulfatoxymelatonin (aMT6s) excretion in the urine of patients in the group with a biodynamic lighting system (BDL) and the control group during inpatient stays.

aMT6s Excretion in Urine (ng/12h)
Day BDL
(n=27)
Control
(n=20)
p Value
First day 12600
(6222-19775)
10490
(5080-19561)
0.715
Day 3 15840
(10140-22160)
6141
(2080-11328)
0.006
Day 5 18780
(11320-23562)
6380
(3500-17600)
0.012

The data are expressed as the median (IQR).